{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:08:40Z","timestamp":1773680920201,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.neuroscience.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T12:36:48Z","timestamp":1200400608000},"page":"773-784","source":"Crossref","is-referenced-by-count":48,"title":["Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges"],"prefix":"10.1016","volume":"152","author":[{"given":"M.H.","family":"Baumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.H.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2008.01.007_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainres.2003.09.037","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors","volume":"994","author":"Ball","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3565(24)29607-5","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions","volume":"297","author":"Bankson","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib3","first-page":"911","article-title":"3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites","volume":"242","author":"Battaglia","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib4","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1523\/JNEUROSCI.18-21-09069.1998","article-title":"Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats","volume":"18","author":"Baumann","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.npp.1300585","article-title":"N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u201cecstasy\u201d)","volume":"30","author":"Baumann","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings","volume":"189","author":"Baumann","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-005-0278-y","article-title":"Initial deficit and recovery of function after MDMA preexposure in rats","volume":"184","author":"Brennan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib8","first-page":"325","article-title":"Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+\/\u2212)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response","volume":"275","author":"Broening","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib9","first-page":"318","article-title":"Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist","volume":"263","author":"Callaway","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02246026","article-title":"Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists","volume":"104","author":"Callaway","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d): psychomotor performance and subjective effects","volume":"20","author":"Cami","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.1360-0443.2002.00222.x","article-title":"The content of ecstasy tablets: implications for the study of their long-term effects","volume":"97","author":"Cole","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib13","first-page":"338","article-title":"Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain","volume":"241","author":"Commins","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0031-9384(95)00136-7","article-title":"Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing","volume":"58","author":"Dafters","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tips.2004.08.001","article-title":"Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans","volume":"25","author":"de la Torre","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0269881106061153","article-title":"Ecstasy: are animal data consistent between species and can they translate to humans?","volume":"20","author":"Easton","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-006-0320-8","article-title":"Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?","volume":"189","author":"Fantegrossi","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.npp.1300442","article-title":"Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys","volume":"29","author":"Fantegrossi","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farre","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0892-0362(95)00013-H","article-title":"Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys","volume":"17","author":"Frederick","year":"1995","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0149-7634(95)00064-X","article-title":"Effects of MDMA on complex brain function in laboratory animals","volume":"21","author":"Frederick","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib22","first-page":"277","article-title":"Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo","volume":"279","author":"Gartside","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-3223(99)00180-8","article-title":"Long-lasting effects of (+\/\u2212)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans","volume":"47","author":"Gerra","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-199801000-00001","article-title":"Serotonergic function after (+\/\u2212)3,4-methylene-dioxymethamphetamine (\u201cecstasy\u201d) in humans","volume":"13","author":"Gerra","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2005.07.036","article-title":"Previous exposure to (+\/\u2212) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility","volume":"136","author":"Giorgi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0091-3057(92)90405-5","article-title":"Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline","volume":"43","author":"Glennon","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib27","first-page":"547","article-title":"Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats","volume":"247","author":"Gold","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0091-3057(03)00029-7","article-title":"Serotonergic-dopaminergic mediation of MDMA\u2019s discriminative stimulus effects in a three-choice discrimination","volume":"74","author":"Goodwin","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2002.tb04182.x","article-title":"Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study","volume":"965","author":"Gough","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","article-title":"Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions","volume":"66","author":"Gudelsky","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2396(199907)33:1<16::AID-SYN2>3.0.CO;2-8","article-title":"Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior","volume":"33","author":"Hall","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","article-title":"Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"162","author":"Harris","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-0173(99)00023-5","article-title":"The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking","volume":"31","author":"Ikemoto","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2005.05.003","article-title":"Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo","volume":"81","author":"Johanson","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0893-133X(97)00195-4","article-title":"MDMA elicits behavioral and neurochemical sensitization in rats","volume":"18","author":"Kalivas","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0091-3057(97)00527-3","article-title":"The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens","volume":"59","author":"Kankaanpaa","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/syn.890200202","article-title":"Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum","volume":"20","author":"Kirby","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/frne.1994.1006","article-title":"Monoaminergic regulation of neuroendocrine function and its modification by cocaine","volume":"15","author":"Levy","year":"1994","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib40","first-page":"1202","article-title":"Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics","volume":"26","author":"Lin","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130050978","article-title":"Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat","volume":"144","author":"Marston","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0306-4522(01)00539-5","article-title":"Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine","volume":"110","author":"Matuszewich","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3565(24)34994-8","article-title":"Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B\/1D) receptors","volume":"290","author":"McCreary","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib46","first-page":"873","article-title":"Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine","volume":"245","author":"Nash","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib47","series-title":"Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA","first-page":"225","article-title":"Neuroendocrinological effects of MDMA in the rat","author":"Nash","year":"1990"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","article-title":"The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u201cecstasy\u201d)","volume":"37","author":"O\u2019Shea","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881105048900","article-title":"Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy","volume":"19","author":"Parrott","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib50","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib51","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.105.095760","article-title":"Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist","volume":"317","author":"Piper","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002130050311","article-title":"Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA","volume":"131","author":"Poland","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000026664","article-title":"(+\/\u2212)3,4-Methylenedioxymethamphetamine (\u201cecstasy\u201d)-induced serotonin neurotoxicity: studies in animals","volume":"42","author":"Ricaurte","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(02)00234-6","article-title":"Therapeutic and adverse actions of serotonin transporter substrates","volume":"95","author":"Rothman","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-3057(88)90390-5","article-title":"Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"31","author":"Schechter","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0091-3057(91)90010-Y","article-title":"Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination","volume":"38","author":"Schechter","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib57","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0269881106060147","article-title":"Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994\u20132003)","volume":"20","author":"Schifano","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF02247485","article-title":"p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo","volume":"116","author":"Series","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s002130051143","article-title":"A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration","volume":"147","author":"Shankaran","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib60","first-page":"529","article-title":"Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate","volume":"10","author":"Slikker","year":"1989","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(89)90044-0","article-title":"Acute and subchronic effects of methylenedioxymethamphetamine [(+\/\u2212)MDMA] on locomotion and serotonin syndrome behavior in the rat","volume":"32","author":"Spanos","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib62","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/0028-3908(87)90117-1","article-title":"Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat","volume":"26","author":"Stone","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hup.529","article-title":"Acute, sub-acute and long-term subjective consequences of \u201cecstasy\u201d (MDMA) consumption in 430 regular users","volume":"18","author":"Verheyden","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002130000563","article-title":"Cognitive performance and serotonergic function in users of ecstasy","volume":"153","author":"Verkes","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00008877-199903000-00008","article-title":"Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+\/\u2212)-MDMA neurotoxicity: protection by fluoxetine","volume":"10","author":"Virden","year":"1999","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroscience.2007.05.024","article-title":"Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan","volume":"148","author":"Wang","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib67","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.105.088476","article-title":"(+\/\u2212)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane","volume":"314","author":"Wang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","article-title":"The effects of methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) on monoaminergic neurotransmission in the central nervous system","volume":"49","author":"White","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2008.01.007_bib69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0091-3057(90)90301-W","article-title":"Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine","volume":"35","author":"Zacny","year":"1990","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T18:48:18Z","timestamp":1737830898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452208000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0306452208000365"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2008.01.007","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}